Message from CEO
A large number of patients develop liver diseases over the world, but the patients who can receive donor livers are very little. For the liver disease treatment, the liver cell sheets, which made of mesenchymal stem cells (MSCs) in human living body, have been developed by Prof. Goshi Shiota of Tottori University. (Sci Rep. 2015, 5: 16169.)
The liver cell sheet treatment can reduce both acute injuring and liver fibrosis caused by chronic injuring, by putting onto the liver surface. Liver fibrosis become worse to liver cirrhosis and carcinogenesis. So, we expect that liver cell sheets will be an effective treatment for these liver disease.
I am challenging research and development in order to offer you this wonderful technology.
President and CEO, KanonCure Inc.
|Adress||Tottori Univ. Alesco Bldg. 604,
86 Nishi-cho, Yonago, Tottori,
|Established||April 25, 2016|
|Capitalization||JPY 13,000,000 Yen|
|Unquoted share||40,000 shares|
|President & CEO||Yohei KONO|
|Business Overview||Research and development of regenerative medical products|